Victory Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.7K Sell
30,843
-341
-1% -$610 ﹤0.01% 2329
2025
Q4
$58.3K Buy
31,184
+725
+2% +$1.39K ﹤0.01% 2316
2025
Q3
$39K Sell
30,459
-1,040
-3% -$1.41K ﹤0.01% 2363
2025
Q2
$39.1K Buy
31,499
+2,134
+7% +$2.46K ﹤0.01% 2401
2025
Q1
$34.7K Sell
29,365
-546
-2% -$838 ﹤0.01% 2392
2024
Q4
$54.7K Sell
29,911
-3,638
-11% -$7.1K ﹤0.01% 2384
2024
Q3
$57K Sell
33,549
-580
-2% -$953 ﹤0.01% 2380
2024
Q2
$46.8K Buy
34,129
+942
+3% +$1.9K ﹤0.01% 2374
2024
Q1
$124K Sell
33,187
-1,061,537
-97% -$6.22M ﹤0.01% 2276
2023
Q4
$10.7M Buy
1,094,724
+442,250
+68% +$3.62M 0.01% 1028
2023
Q3
$5.45M Sell
652,474
-1,191,647
-65% -$13.6M 0.01% 1193
2023
Q2
$24.5M Buy
1,844,121
+192,332
+12% +$2.34M 0.03% 694
2023
Q1
$19.1M Buy
1,651,789
+1,628,823
+7,092% +$16.2M 0.02% 803
2022
Q4
$188K Sell
22,966
-9
-0% -$78 ﹤0.01% 2279
2022
Q3
$133K Buy
22,975
+2,171
+10% +$12.5K ﹤0.01% 2428
2022
Q2
$92K Buy
20,804
+157
+0.8% +$954 ﹤0.01% 2468
2022
Q1
$131K Sell
20,647
-10,684
-34% -$123K ﹤0.01% 2478
2021
Q4
$641K Sell
31,331
-9,156
-23% -$221K ﹤0.01% 2034
2021
Q3
$1.03M Buy
40,487
+2,059
+5% +$61K ﹤0.01% 1849
2021
Q2
$1.34M Sell
38,428
-1,723
-4% -$50.1K ﹤0.01% 1778
2021
Q1
$1.34M Buy
40,151
+2,312
+6% +$80.9K ﹤0.01% 1773
2020
Q4
$982K Buy
37,839
+11,440
+43% +$194K ﹤0.01% 1791
2020
Q3
$261K Buy
26,399
+2,308
+10% +$13.3K ﹤0.01% 2206
2020
Q2
$83K Sell
24,091
-25,249
-51% -$86K ﹤0.01% 2368
2020
Q1
$150K Buy
49,340
+17,559
+55% +$71.9K ﹤0.01% 2410
2019
Q4
$163K Sell
31,781
-961
-3% -$4.88K ﹤0.01% 2369
2019
Q3
$169K Buy
+32,742
New +$183K ﹤0.01% 2271
2018
Q4
Sell
-300,000
Closed -$1.62M 1805
2018
Q3
$1.62M Buy
+300,000
New +$1.29M ﹤0.01% 1143

Other funds holding PACB